1192 results for Support
Refine Your Search
Mayra
I am years old and a mother of two. Last year on December , , I was diagnosed with acute myeloid leukemia (AML), an aggressive blood cancer. My world…
Dare 2 Dream
Peyton
My son, Peyton, was diagnosed with lymphoma (NHL) in when he was just eight years old. I nearly dropped to the ground in devastation when I heard th…
Dare 2 Dream
Daniel (Lil Sicky)
Cancel blood cancer with web3! Daniel is a - lymphoma patient who combined his medical diagnosis and love of digital art into an NFT project supportin…
Joan
In October , I was handing out candy to my neighborhood’s tiny ghouls and goblins, but the scariest thing that Halloween was a phone call from my doct…
Max
Heads or tails? The medical research was clear. Soon after making his way into the world, this beautiful and innocent boy was given the chance of maki…
Mollie
Although I was a blood cancer patient many years ago, survivorship is a journey I take every day. Ever since my diagnosis, I’ve spent my free time eng…
Stories
Jennifer
In , - Jennifer took to the stage to accept The Leukemia & Lymphoma Society’s (LLS) “Employee of the Year” award for her mother, Teresa McVay, who had…
Inside Myeloma Rounds: Expert Discussion and Updates
Click Here to Participate Recorded on: September , . CME Credits for physicians and physician associates available until: October , . CPE Contact hour…
Isabel
I never expected to have my whole adult life colored by cancer. In the fall of my freshman year of college, I was diagnosed with chronic myelogenous l…
Ryan
My name is Ryan, and I’m a - Honorary Hero for Blood Cancer United. In October , my life was turned upside down in a matter of moments. What started a…
Stories
FAQs: Proposed federal spending cuts and blood cancer research and care
The Leukemia & Lymphoma Society (LLS) has heard great concerns from patients, caregivers, volunteers, healthcare professionals, researchers, community…
News Release
A phase 2 study of RVU120, a novel CDK8 inhibitor, in combination with venetoclax in patients with AML
In August , TAP partnered with Ryvu Therapeutics (formerly known as Selvita) to support "A Phase 1b Study of SEL120 in Patients With Acute Myeloid Leu…
Living Well with Blood Cancer
Join the Indiana Blood Cancer community for an engaging and informative program exploring:The latest advances in blood cancers with our panel of local…
Jill
When my husband, Farris, was diagnosed in with chronic myeloid leukemia (CML), he enrolled in the Blood Cancer clinical trial for Gleevec. Shortly a…
Stories
Centers for Disease Control and Prevention (CDC)
Collaborating to create the expertise, information, and tools that people and communities need to protect their health – through health promotion, pre…
Katharine
As a physician myself, I had some idea of the ramifications of a cancer diagnosis. However, when my own , previously healthy daughter was diagnosed wi…
A phase 1 study of AUTX-703, a KAT2A/B degrader, in patients with AML or MDS
In June , LLS made an equity investment in Auron Therapeutics to "Support Clinical Development of in Relapsed/Refractory AML and MDS."Auron Therapeut…
Research: TAP
The Immune Niche in the Development of Hematological Malignancies and Implications for Novel Therapy
Our SCOR Program, composed of four complementary Projects supported by three shared Cores, is designed to determine how the immune niche and factors i…
Tracey
I was diagnosed with chronic lymphocytic leukemia (CLL) in after a routine physical after my 50th birthday. It was a complete shock and I was scared …
A phase 2 study of RVU120, a novel CDK8 inhibitor, in patients with myelofibrosis
In August , TAP partnered with Ryvu Therapeutics (formerly known as Selvita) to support "A Phase 1b Study of SEL120 in Patients With Acute Myeloid Leu…
Suggested Reading - Coping with the Emotional Impact of Cancer: Become an Active Patient and Take Charge of Your Treatment
The author of this book is a -year survivor of a terminal cancer diagnosis, dramatically demonstrates how patients can maintain personal control of th…
A phase 1 study of CB-010, a CRISPR-edited allogeneic CAR-T targeting CD19, in patients with B-cell NHL
In February , LLS made an equity investment in Caribou Biosciences to support "A Phase , Multicenter, Study of , a Allogeneic Cell Therapy in Pati…
A phase 1 study of CB-011, a CRISPR-edited allogeneic CAR-T targeting BCMA, in patients with multiple myeloma
In February , LLS made an equity investment in Caribou Biosciences to support "A Phase , Multicenter, Study of , a Allogeneic Cell Therapy in Pati…
Pilar
My name is Pilar and I am years old. I used to work for the workforce board of Philadelphia, working with youth, until I was diagnosed with acute mye…
Berenise
On October , , as a senior in college, I was spontaneously diagnosed with acute myeloid leukemia (AML). I was immediately admitted into the hospital …
Stories